New hope for kidney stone sufferers: supplement may stop painful recurrences
NCT ID NCT06003348
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tests whether hydroxycitrate, a molecule similar to citrate, can reduce the recurrence of calcium phosphate kidney stones. Researchers will give 25 stone formers either hydroxycitrate, potassium citrate, or a placebo, and measure how well their urine prevents stone formation. The goal is to find a simple, accessible therapy to keep these painful stones from coming back.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- Hydroxycitrate (dietary supplement)
- What this could lead to
- If it works, this could offer a new way to prevent calcium phosphate kidney stones from coming back.
- What could go wrong
- This is a small early-phase trial with only 25 people, so results may not apply to everyone. The supplement is not FDA approved or regulated.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CALCIUM PHOSPHATE KIDNEY STONES are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
UT Southwestern Medical Center
RECRUITINGDallas, Texas, 75390-8885, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.